LMR Partners’s Century Therapeutics IPSC Stock Holding History

LMR Partners’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-49,323	Closed	-$1.45M	–	1093
2021 Q2	$1.45M	Buy	+49,323	New	+$1.25M	0.02%	452

Other funds holding IPSC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

LMR Partners's IPSC Position: Q3 2021 in Review

LMR Partners sold out of Century Therapeutics (IPSC) in Q3 2021, closing a stake of 49,323 shares — an estimated $1.45M sold.

LMR Partners first reported a position in IPSC in Q2 2021 and held it in 1 quarter. The position peaked at $1.45M in Q2 2021. 49 funds tracked by Wall St. Rank hold IPSC as of Q3 2021.

LMR Partners reported no remaining Century Therapeutics position as of Q3 2021 after selling out during the quarter.
LMR Partners sold 49,323 Century Therapeutics shares in Q3 2021, an estimated $1.45M.
LMR Partners first reported a position in Century Therapeutics in Q2 2021 and held it in 1 quarter.
LMR Partners's Century Therapeutics position peaked at $1.45M in Q2 2021.
49 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2021.

Based on LMR Partners's 13F filing for Q3 2021, filed 15 Nov 2021.